AKRO Investors Have Opportunity to Lead Akero Therapeutics,

NEW YORK, June 11, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Akero...

Related Keywords

New York , United States , China , Chinese , Laurence Rosen , Phillip Kim , Nasdaq , Chinese Company , Twitter , Linkedin , Securities Class Action Services , Facebook , Rosen Law Firm , Us Food Drug Administration , Akero Therapeutics Inc , Akero Therapeutics , Class Period , Law Firm , Class Action Services , Non Alcoholic Steatohepatitis , Drug Administration , Class Has Been ,